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Abstract        The members of the mitogen-activated protein kinase family participate in cellular responses to 
a wide range of extracellular stimuli. One of the four sub-families, the p38 group MAP kinases, plays a vital role in 
numerous biological processes. The p38 signaling pathway can be activated in response to many physical, chemical, 
and biological stresses, including UV light, heat shock, osmotic shock, inflammatory cytokines, and growth factors. 
The p38 pathway also regulates various physiological processes such as cell differentiation, the cell cycle, and 
inflammation. This review focuses on the characteristics of each p38 member, the components of the p38 pathway, 
and the mechanisms and consequences of p38 activation. We also discuss the interplay between the p38 pathway 
and other signaling pathways.
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过 程。MAPKs家 族 包 括ERKs(extracellular signal-
regulated kinases)、JNK/SAPK(c-jun N-terminal or 
stress-activated protein kinases)、ERK5/BMK(ERK/















(tumor necrosis factor, TNF)等炎症因子的产生[4]。另
外, 该蛋白能够在细胞受到热击、亚砷酸盐或IL-1
作用时激活MAPK活化蛋白激酶2(MAPK-activated 




























2   p38信号通路的激活









2.2   经典的p38信号通路的激活方式
几乎在所有的不良刺激的作用下, p38活化环上
的苏氨酸和酪氨酸两个位点都会被MAPK激酶(MAP 























































3   p38信号通路的调控
























































Different stimuli such as inflammatory cytokines or environmental stresses can activate p38 MAPKs through kinase cascades. The activated p38 group 
members can regulate a number of downstream targets, including protein kinases, cytosolic substrates and transcription factors to mediate cellular 
responses to the stimuli.
图1 p38信号通路












































































4.2   位于核内的p38磷酸化底物
在不同刺激的作用下p38会磷酸化并激活不同

































































损伤时, p38会转移入核, 并启动G2/M期检测点, 促进
DNA的修复[89]。






















































7   p38的生理学功能
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